Search

Protect yourself by obtaining a vaccination against COVID-19 and the Delta strain if you are 12 years or older; seek urgent care if needed The world, the country and our area continue to experience an increase in COVID-19 cases and hospitalizations with the highly contagious Delta SARS-CoV-2 virus strain. The Renown Health team continues to safely screen, diagnose and care for patients with respiratory illnesses, including those at risk for COVID-19. Renown continues to use current local and national data, analytics, and public data sets for predictive modeling in service to our community. Renown Health ensures constant readiness by working closely with the Washoe County Health District, the Governor’s office, and is informed by updates from the Centers for Disease Control and Prevention (CDC). When there is heightened concern around an illness, we implement enhanced infection prevention strategies to ensure we are ready with the appropriate supplies and alternate plans should the need arise. Renown Health providers are educated and prepared to quickly and safely screen, diagnose and care for patients with respiratory illness, including COVID-19. Vaccination is the best protection against Delta. “The most important action you can take to protect yourself from the Delta strain and the COVID-19 virus is to get fully vaccinated,” says Brion Hill, MD who practices at the Renown Urgent Care - Los Altos location. “The COVID 19 virus and Delta strain is preventable and controllable through safe and effective COVID-19 vaccines, which are free and now widely available in our area. The CDC recommends all people 12 years and older be vaccinated against COVID-19. Recent data show that nearly all COVID-19 deaths are now occurring among unvaccinated individuals.” A list of providers in our area offering vaccines is available at vaccines.gov.” Protecting Yourself, Friends and Family Dr. Hill adds, “You can protect yourself the same way you would protect against other viruses with a few common-sense practices.” Wear a cloth mask or medical procedure mask when in a public setting. For situations when you are in close contact with people who do not live with you, you may want to consider a mask option that provides a higher level of protection (improved fit and/or improved filtration). Wash your hands thoroughly and often. Make sure you are cleaning between your fingers and under your nails. Use alcohol-based sanitizers when soap and water are not available. Use disposable tissues when coughing and sneezing; dispose of carefully and promptly. If tissues are not available, direct your cough or sneeze into the crook of your arm/sleeve. Avoid touching your eyes, nose, and mouth with unwashed hands. Clean and disinfect frequently touched objects and surfaces. Avoid close contact with anyone who has cold or flu-like symptoms. Avoid shaking hands, especially with those who appear to be ill. Disinfect shared surfaces. Practice social distancing, 6 feet or more. Stay home when you are sick. If you have fever, cough, gastrointestinal, or respiratory symptoms please call your medical provider and explain your symptoms before coming in to their offices. If you do not have a health care provider, and have medical concerns that are urgent but not life-threatening, visit a Renown Urgent Care physician or healthcare provider. Virtual Urgent Care is available for people for COVID-19 symptoms and Virtual Urgent Care visits are available through MyChart. MyChart is a free, secure online patient portal that allows you to access your Renown Health medical record and manage your health care information. There are 11 conveniently located Renown Urgent Care offices with providers ready to see you 7 days a week. You have the option to book ahead and schedule an appointment at 11 locations near you. How to Get Accurate and Reliable Information: We continue to advise our community regarding the importance of accurate sources of information, and to provide regular updates. For up-to-date information on Renown’s approach to keeping our community safe, visit our website at renown.org.     About Renown Health Renown Health is a locally governed, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, the region’s only children’s hospital, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to improving the care and the health of our community. For more information, visit renown.org.

Read More About Fighting for Your Health and Safety; As COVID-19 Cases Rise, Renown is Prepared

Freenome, a privately held biotech company announced today that Renown Health has joined as a partner for the Sanderson Study, Freenome’s study of its multiomics platform, in combination with real-world data to detect multiple cancers. The study encompasses both traditional and real-world data to generate evidence of clinical validation for certain high- and elevated-risk populations while also refining the platform’s cancer classification and risk prediction models. In addition, the Sanderson Study will build the necessary infrastructure to bridge the gap between clinical research and day-to-day clinical impact. Freenome uses a multiomics platform that combines tumor and non-tumor signals with machine learning to detect cancer in its earliest stages using a standard blood draw. “We are delighted to partner with Freenome to launch this far-reaching trial which has transformative potential,” said Lee Schwartzberg, MD, medical oncology section chief and the principal investigator for the Sanderson Study at Renown. “Studying the impact of merging real-world information from patients with multiomics technology holds the promise of a truly personalized approach to early detection of cancer.” Renown Health has multiple clinical trials currently available to patients in northern Nevada across a variety of specialties, including oncology, cardiology, neurology, pediatrics, and pulmonology. Cancer is the second-leading cause of death in the Silver State, claiming the lives of more than 5,400 Nevadans each year. This number has increased since the last five-year plan estimates of 4,400 deaths per year.1 Promoting research to improve cancer prevention, detection, diagnosis and treatment is a key goal outlined in the Nevada Cancer Plan, 2021-2025, a framework developed by the Nevada Cancer Coalition in partnership with the Nevada Department of Health and Human Services. Access and participation in clinical trials is a key component of the plan, which, Renown says, makes participation in the Sanderson Study even more significant. “At the inception of the William N. Pennington Cancer Institute, we committed to not only provide the very best care possible to our community, but to also help improve outcomes through participation in research,” said Max Coppes, MD, PhD, MBA, cancer center director of the William N. Pennington Cancer Institute. “The research collaboration with Freenome has the potential to make a dream come true: Finding cancer early when it’s most treatable.” The Sanderson Study will enroll approximately 8,000 patients through Freenome’s clinical study partner network and numerous regional health systems across the United States. “Renown is committed to making a difference in the health and well-being of patients in communities across the state of Nevada, and that includes access to innovative research,” said Lance Baldo, MD, chief medical officer at Freenome. “The combination of real-world data and multiomics is poised to transform the landscape of early cancer detection.” Freenome’s clinical studies are named for employees’ loved ones who fought cancer. This study honors Tim Sanderson, the loving father of a Freenome engineer. For residents of Nevada interested in participating in the Sanderson Study, contact the William N. Pennington Cancer Institute clinical research coordinators at renown-crd@renown.org. Click here for more information on the Sanderson Study. About Freenome Freenome is a biotechnology company with a comprehensive multiomics platform for the early detection of cancer using a standard blood draw. The company combines its deep expertise in molecular biology with advanced computational biology and machine learning to detect disease-associated patterns among billions of circulating cell-free biomarkers. Freenome is headquartered in South San Francisco, California. About Renown Health’s William N. Pennington Cancer Institute The William N. Pennington Cancer Research Institute provides comprehensive multidisciplinary cancer care for the northern Nevada community, helps educate the next generation of healthcare providers, and works to improve treatments and outcomes through active participation in research. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health.

Read More About Freenome Adds Renown Health As Partner for The Sanderson Study

Renown’s Surgical Oncology team amongst the first to use HistoSonics' image guided histotripsy system to deliver non-invasive, personalized treatments for patients with liver tumors, thanks to a private donation. Watch this video to learn more about the technology.  Renown Health announced today that the first patients have received targeted liver tumor treatments through the Edison® System histotripsy technology, which uses focused ultrasound waves to noninvasively destroy a designated tissue or tumor in the liver. This revolutionary technology represents a significant advancement in providing leading-edge surgical care to patients. Renown joins the Cleveland Clinic, Mayo Clinic and Johns Hopkins in being amongst the first in the country to offer this revolutionary non-invasive clinical procedure. Surgical oncologists Christos A. Galanopoulos MD, MBA, MSc, FACS; Nicholas Manguso, MD; and Randy Zuckerman, MD of the William N. Pennington Cancer Institute at Renown Health, are amongst the first physicians in the world trained to perform the procedure which destroys both primary and metastatic liver tumors, including those that can’t otherwise be removed surgically. Renown’s multidisciplinary team includes surgical oncologists, radiologists, oncologists and nurses who collaborate to provide comprehensive care tailored to each patient’s needs.  “At Renown Health, we are constantly investing in our clinicians, essential services, and medical innovations to help keep care local,” said Brian Erling, MD, MBA, President & CEO for Renown Health. “We are grateful to a generous local donor, who provided us with a $1.4-million private donation to help purchase the equipment, training and to establish one of the few histotripsy programs in the U.S. at Renown. This non-invasive technology is a game changer in helping our liver surgeons and surgical oncologists to target and destroy malignant tissue in patients with either liver cancer or tumors that have spread to the liver from cancers based elsewhere in the body. This means people can now stay close to home and loved ones, and no longer need to leave Nevada for this type of advanced care.”  “As a surgeon, it’s rewarding to offer a procedure where we can precisely destroy liver tumors without using a scalpel or needles, enabling a patient’s quick recovery while avoiding certain complications common with other modalities,” says Dr. Christos Galanopoulos, Chair, Department of Surgery at Renown Health, and one of the oncology surgeons trained to perform the HistoSonics procedure. “Histotripsy uses focused ultrasound waves to mechanically destroy targeted tissue, offering a promising alternative to traditional surgical methods. This non-invasive approach reduces recovery time, minimizes complications, and improves patient outcomes. We look forward to the role this innovative technology will have in our treatment plans going forward.”  Revolutionary Technology “Histotripsy is a novel form of therapeutic ultrasound that precisely targets and liquefies tissue without damaging surrounding structures,” says Dr. Randy Zuckerman, surgical oncologist at Renown. “The system works by sending out focused ultrasound to targeted areas of tissue. The ultrasound energy creates pressure in the targeted tumor causing naturally existing gas bubbles to rapidly expand and collapse, helping break down and liquefy the targeted tissue. The entire process—from pre-treatment planning to real-time visualization—is assisted by advanced imaging technologies. We are confident that histotripsy will have a meaningful impact for patients suffering from unresectable liver disease, including liver tumors, and we are excited to share this advancement with our patients and community.”  The HistoSonics Edison® System and histotripsy procedure allows for: Precision and Accuracy: Histotripsy targets only the tumor cells, sparing adjacent healthy tissue, which is particularly advantageous in treating tumors located near critical structures.  Non-Invasiveness: As a completely non-invasive procedure, histotripsy eliminates the need for incisions, resulting in less pain and potentially faster recovery times for patients.  Reduced Risk of Complications: With no need for surgical intervention, patients face a lower risk of infection, bleeding, and other post-operative complications commonly seen in more invasive procedures. Renown’s Commitment to Innovation “The introduction of histotripsy underscores Renown Health’s dedication to staying at the forefront of medical advancements,” says Bill Plauth, MD, Chief Medical Officer for Renown Health and Associate Dean for Clinical Affairs at the University of Nevada, Reno School of Medicine. “By continually investing in the latest technologies and treatment modalities, we can ensure that patients receive the highest standard of care - right here in Reno.” Clinical trial results recently shared by the company showed that physicians were able to achieve a technical success rate of 95.5% in targeting and destroying malignant tissue in 44 patients with either liver cancer or tumors that had spread to the liver from cancers based elsewhere in the body.  Thanks to the Generosity of Our Community  "Through the generosity of our community, we are working to provide the best expertise, technology and programs for our patients,” said Greg Walaitis, Chief Development Officer, Renown Health Foundation. “As the only charitable, not-for-profit integrated academic healthcare organization in Reno, we appreciate that our community has helped us further our healing mission."  For more information about supporting innovative clinical care at Renown Health, visit www.renown.org/Foundation. To schedule a new patient appointment with the William N. Pennington Cancer Institute at Renown Health at 1155 Mill St in Reno, NV, call 775-982-4000. To schedule a patient for the HistoSonics procedure, call Dr. Christos Galanopoulos’ office (Renown Surgical Care) at 775-982-6270.  For media interviews, contact news@renown.org or 775-691-7308.  The Edison® System is intended for the non-invasive mechanical destruction of liver tumors, including the partial or complete destruction of unresectable liver tumors via histotripsy. The FDA has not evaluated the Edison System for the treatment of any specific disease or condition. Use of Edison System in kidney applications is limited by federal law to investigational use.     About HistoSonics HistoSonics is a privately held medical device company developing non-invasive platforms and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumors. The company is currently focused on commercializing their Edison System in the US and select global markets for liver treatment while expanding histotripsy applications into other organs like kidney, pancreas, and others. HistoSonics has offices in Ann Arbor, Michigan and Minneapolis, MN.  About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated health care network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,500 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. For more information, visit renown.org.

Read More About Groundbreaking Historic Milestone: Renown Pioneers Histosonics Edison® System Delivering Histotripsy for Non-Invasive Liver Tumor Treatment

Renown Health & Hometown Health leverage cloud technology to improve access to care and coverage A person’s ability to access health services has a profound effect on every aspect of his or her health, yet almost 1 in 4 Americans do not have a primary care provider (PCP) or a health center where they can receive regular medical services. In addition, because of concerns about COVID-19, the CDC reports that an estimated 41% of U.S. adults have delayed or avoided medical care including urgent or emergency care (12%) and routine care (32%). Avoidance of urgent or emergency care was more prevalent among unpaid caregivers for adults, persons with underlying medical conditions, Black adults, Hispanic adults, young adults, and persons with disabilities. With the goal of improving health by helping people get the healthcare services they need, Renown Health, based in Reno, NV, is leveraging Amazon Web Services (AWS) to enhance access to care. As part of Renown’s continued journey to transform healthcare, the healthcare network is implementing Amazon Connect – AWS’s omnichannel cloud contact center service. The easy to use and quick to deploy solution allows patients to easily access customer service for Renown’s Hometown Health insurance plan, schedule imaging appointments, Epic MyChart patient electronic medical record support and general customer service. Customer service is now available in multiple languages over the phone, and via online live agent chat and email, making it easier and more convenient for people to make appointments for the care they need. Amazon Connect enables Renown Health to scale up to handle unexpected high call volumes and scale back rapidly. The solution also provides call center agents the flexibility they need to work remotely, without compromising the customer experience. “Renown is proud to be one of the first nonprofit healthcare organizations in the country to use Amazon Web Services as part of a comprehensive customer access and outreach program,” says Tony Slonim, MD, DrPH, President & CEO, Renown Health. “We are excited to deploy their innovative contact center technology to assist us in connecting people with Renown medical providers and health services. Our goal is to make connections quick, easy and convenient, so more people will be encouraged to receive the health care services they need.” “Today’s generation of healthcare consumers expect a friction-less experience—from finding a caregiver, to booking an appointment, to receiving treatment. With this new solution, Renown Health will be able to meet their customers’ expectations faster and more efficiently than ever before,” said Phoebe Yang, General Manager, Healthcare at AWS. “AWS looks forward to working with the innovative team at Renown Health as they leverage the power of the cloud to improve the health of communities they serve." “Especially with COVID, but even before, many people don’t get recommended healthcare services, like cancer screenings, because they lack a primary care provider, or access to health care professionals. At Renown Health, we have a commitment to caring for people, with Reliable and Exact Care and the ability to connect — in person and virtually — to help ensure people get the care they need, when and where they need it,” says Thomas Graf, MD, Chief Clinical & Quality Officer at Renown. “Our goal is to reduce barriers and enhance access, so all who need care can receive care,” says Candace Dietrich, director of the Engagement Center at Renown. “AWS technology is helping to improve the customer experience and drive efficiencies. Our collaboration with AWS makes health care more accessible for all, which ultimately is better for the entire community.” “Amazon Connect is a key component of our digital front door virtual care strategy and supports our customer service goals and Reliable & Exact Care at Renown,” said Chuck Podesta, Chief Information Technology Officer at Renown. “Hometown Health is a community-focused organization and with support from AWS, we continue to improve the health and well-being of the communities we serve,” says David Hansen, Chief Executive Officer of Nevada’s largest not-for- profit health insurance provider. “We are proud to have a care and coverage network serving half a billion people across 100,000 square miles across Nevada, Lake Tahoe and northeast California, and committed to creating healthier communities.” About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.

Read More About Renown Health Works With Amazon Web Services To Enhance Customer Experience

Under Steve Shell's leadership, the Institute will continue to expand community access to prevention and intervention services for mental health disorders and alcohol and drug addiction. Renown Health is excited to announce Steve Shell is joining the Stacie Mathewson Behavioral Health & Addiction Institute at Renown as its vice president. In this role, Shell will oversee the Institute, which provides intensive outpatient treatment, partial hospitalization programs and medication-assisted treatment to serve those struggling with mental illness and addiction in our community. “We are pleased to welcome such an experienced and talented leader like Steve to our organization,” said Tony Slonim, MD, DrPH, president and CEO, Renown Health. “As vice president of the Stacie Mathewson Behavioral Health & Addiction Institute at Renown, Steve will continue the Institute’s work to change the status of mental health and addiction in northern Nevada.” Shell comes to Renown after opening and serving as chief executive officer of Nevada’s two newest behavioral health hospitals since 2013. He was instrumental in establishing Reno Behavioral Healthcare Hospital in 2016 and helped to design, set up and manage operations for the 124-bed psychiatric and addiction treatment facility for all ages. He also launched the 152- bed Desert Parkway Behavioral Healthcare Hospital in Las Vegas in 2013, a psychiatric and addiction treatment facility for all ages. “Nevada has the highest prevalence of mental illness and substance use in the nation combined with limited access to treatment and a shortage of care providers,” said Steve Shell. “I am passionate about improving the health of our community and have dedicated my career to advocating for mental health, working diligently to further elevate the care offered in our state.”  Renown Health and Charles N. and Stacie L. Mathewson established the Stacie Mathewson Behavioral Health & Addiction Institute at Renown in to expand community access to prevention and intervention services for mental health disorders and alcohol and drug addiction.  The Institute is working to expand intensive outpatient treatment, partial hospitalization programs and medication-assisted treatment to better serve those struggling with mental illness and addiction and is working to decrease stigma and encourage more people to seek help. “Moving the needle and improving the heartbreaking statistics of our state is a key focus for the Institute,” said Stacie Mathewson, executive director at the Stacie Mathewson Foundation. “I believe Steve’s leadership will have a positive impact on our efforts to improve the care and treatment of mental illness and addiction.”      About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Heath, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®.

Read More About Steve Shell Joins Renown to Lead the Stacie Mathewson Behavioral Health & Addiction Institute

The pandemic has changed the way we live and work. The world is changing, health care has changed and Renown is changing with it. Today, after a comprehensive review, leaders took steps to align the size of Renown’s work force with current patient care volumes. Reductions affected 166 of Renown’s 7,200 employees. A majority of the positions affected are in management and administration. Employees impacted by today’s decision will receive severance pay and full benefits consistent with Renown policy. In addition, there is a hold on hiring 176 employment positions until further notice. The actions taken today are one part of a larger plan to align to the new health care environment. Renown has implemented new models of care to add value, reduce costs, and to help more people receive the health care they need. Renown Health continues to recruit for clinical roles and those areas that support direct patient care.     About Renown Health Renown Health is a locally governed, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, the region’s only children’s hospital, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to improving the care and the health of our community. For more information, visit renown.org.

Read More About Renown Realigns to New Healthcare Environment